From Tunnels to Treatment: Advancing HS Management - Episode 9
Listening to patients and eliciting their history surfaces disease that a limited exam misses. The panel emphasizes trust, undoing blame and stigma, and treating patients as partners in care.
In "HS Care Priorities: Patient-Reported Outcomes, Trust, and Stigma," our experts turn to the one practice change they hope clinicians adopt tomorrow.
Moderator Dr. Porter asks what single change in recognizing or treating HS the panel would like viewers to make tomorrow. The first answer is to use patient-reported outcome scores or otherwise elicit the patient's history, because relying only on what is seen in a limited clinic exam will miss patients who need help now. The panel shares patient feedback that a clinician was the first to let a patient speak about her symptoms and what mattered most to her, whether pain, scarring, or something else. Understanding patient-reported outcomes allows a more holistic, humanistic approach and helps build rapport, which makes follow-up easier even when patients cycle through several medications.
Trust is described as essential because the medical system has often harmed these patients. The disease has historically been blamed on patients, and it has been misidentified as a sexually transmitted infection, leading to incorrect treatment and stigma. The panel notes that sexually transmitted infections are human infections and should be treated like any other infection, though the added burden is real. Undoing that damage takes time and a lot of listening. Patients often arrive with shame and the question of whether they caused it themselves, and clinicians need to reaffirm that this is not their doing. The panel tells patients that draining tunnels will not go away with smoking cessation, weight loss, exercise, or more frequent washing, which patients have heard implied their whole lives.
The panel closes on a hopeful note. Some therapies sound frightening and some are new, but access to biologics has been strong where the panelists practice, and patients regularly say these medications changed their lives. The focus is now widening to hyperpigmentation, scarring, and preventing later sequelae. Dr. Porter thanks the panelists and the clinicians who care for these patients.
Thank you for watching this HCPLive Peer Exchange series on hidradenitis suppurativa. Please subscribe to our eNewsletter for information on upcoming video series.